Team
Experienced hands, a patient-first mission
Leadership spanning biopharma R&D, manufacturing, biophysics, and digital healthcare — united around precision therapies for cancer and infectious disease.
Praveen Kesava
Chairman
35+ years in digital healthcare, wellness, and cancer therapeutics; patient-first focus on democratizing access to care across cancer and infectious disease. Prior leadership at O.TM Biotech, DigitalDots, Exponential Machines, and a global healthcare role at IBM.
Dr. Vishvesh Kumar Bhupathiraju
President & CEO
35+ years across biopharma and academia in R&D and manufacturing. Postdoctoral work at UC Berkeley; PhD in Microbiology (University of Oklahoma). Senior roles incl. Biological E, Stelis Biopharma, Dr. Reddy's Laboratories, Bayer HealthCare, and research at UC Berkeley / Lawrence Berkeley National Lab.
Dr. Francis Fernandes
Chief Scientific Officer & Scientific Advisor
35+ years in biophysics, cancer therapeutics, and infectious disease. PhD in Biochemistry (Ohio University); 11 peer-reviewed publications. Prior science roles at O.TM Biotech (Founder & CSO), Mediclone Biotech, and Hoechst.
Arun Kalasapudi
Executive Director
25+ years building technology products and services for Fortune 1000 companies, with expertise in corporate development and converting strategy into execution. MS in Computer Engineering (Santa Clara University). Prior leadership at Sun Microsystems, Cisco Systems, and Innominds, spanning emerging technology solutions, strategic partnerships, and enterprise AI platforms.
Advisors & Partners
XFBiologics collaborates with established R&D groups in the United States and Canada, and with contract manufacturers in the United Kingdom and Singapore — extending the platform with deep scientific and manufacturing expertise.